Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trialThomas L Holland, Robert C. Hyzy, Lavannya M. Pandit et al.|The Lancet Respiratory Medicine|2022Cited by 127